Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A First in Man Study of MABp1 in Patients With Advanced Cancers

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
XBiotech, Inc.
ClinicalTrials.gov Identifier:
NCT01021072
First received: November 16, 2009
Last updated: October 15, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2013
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)
No publications provided by XBiotech, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):